243 related articles for article (PubMed ID: 30832574)
1. Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction.
Henriksson R; Ulvenstam A; Söderström L; Mooe T
BMC Cardiovasc Disord; 2019 Mar; 19(1):51. PubMed ID: 30832574
[TBL] [Abstract][Full Text] [Related]
2. The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction.
Henriksson R; Björklund F; Mooe T
PLoS One; 2019; 14(5):e0216404. PubMed ID: 31059535
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke rates decrease with increased ticagrelor use after acute myocardial infarction in patients treated with percutaneous coronary intervention.
Ulvenstam A; Henriksson R; Söderström L; Mooe T
Eur J Prev Cardiol; 2018 Jul; 25(11):1219-1230. PubMed ID: 29929389
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
Edfors R; Sahlén A; Szummer K; Renlund H; Evans M; Carrero JJ; Spaak J; James SK; Lagerqvist B; Varenhorst C; Jernberg T
Heart; 2018 Oct; 104(19):1575-1582. PubMed ID: 29574413
[TBL] [Abstract][Full Text] [Related]
5. Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.
Baber U; Leisman DE; Cohen DJ; Gibson CM; Henry TD; Dangas G; Moliterno D; Kini A; Krucoff M; Colombo A; Chieffo A; Sartori S; Witzenbichler B; Steg PG; Pocock SJ; Mehran R
Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004945. PubMed ID: 30606052
[TBL] [Abstract][Full Text] [Related]
6. Incidence, trends, and predictors of ischemic stroke 30 days after an acute myocardial infarction.
Kajermo U; Ulvenstam A; Modica A; Jernberg T; Mooe T
Stroke; 2014 May; 45(5):1324-30. PubMed ID: 24692479
[TBL] [Abstract][Full Text] [Related]
7. One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data.
Kim C; Shin DH; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Hong MK; Park J; Lee H; Kim DS; Oh SK; Jang Y
J Cardiol; 2019 Mar; 73(3):191-197. PubMed ID: 30770037
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome.
Spoendlin J; Gagne JJ; Lewey JJ; Patorno E; Schneeweiss S; Desai RJ
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1361-1370. PubMed ID: 30379372
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Ticagrelor Compared with Clopidogrel in Patients with End-Stage Renal Disease with Acute Myocardial Infarction.
Lee CH; Tsai TH; Lin CJ; Hsueh SK; Chung WJ; Cheng CI
Am J Cardiovasc Drugs; 2019 Jun; 19(3):325-334. PubMed ID: 30746615
[TBL] [Abstract][Full Text] [Related]
10. Stroke in Patients With Peripheral Artery Disease.
Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
[TBL] [Abstract][Full Text] [Related]
11. Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction.
Ulvenstam A; Kajermo U; Modica A; Jernberg T; Söderström L; Mooe T
Stroke; 2014 Nov; 45(11):3263-8. PubMed ID: 25236874
[TBL] [Abstract][Full Text] [Related]
12. Increased Use of Ticagrelor After Myocardial Infarction Is Not Associated With Intracranial Hemorrhage.
Graipe A; Söderström L; Mooe T
Stroke; 2018 Dec; 49(12):2877-2882. PubMed ID: 30571411
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK;
J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.
Fu A; Singh K; Abunassar J; Malhotra N; Le May M; Labinaz M; Glover C; Marquis JF; Froeschl M; Dick A; Hibbert B; Chong AY; So DY;
Clin Cardiol; 2016 Jan; 39(1):19-23. PubMed ID: 26748815
[TBL] [Abstract][Full Text] [Related]
16. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
Zanchin T; Temperli F; Karagiannis A; Zanchin C; Räsänen M; Koskinas KC; Stortecky S; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Billinger M; Heg D; Pilgrim T; Valgimigli M; Windecker S; Räber L
Circ Cardiovasc Interv; 2018 May; 11(5):e006132. PubMed ID: 29748219
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
[TBL] [Abstract][Full Text] [Related]
18. The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction.
Altıntaş B; Altındağ R; Bilge Ö; Baysal E; Öztürk Ö; Yaylak B; Ede H; Karahan MZ; Burak C; Tanboğa İH
Int J Cardiol; 2019 Jul; 287():19-26. PubMed ID: 30979602
[TBL] [Abstract][Full Text] [Related]
19. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention.
Piqueras-Flores J; Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Abellán-Huerta J; Lozano-Ruiz Poveda F
J Cardiovasc Pharmacol; 2019 Jan; 73(1):56-59. PubMed ID: 30383607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
